GS
GSK icon

GTS Securities’s GSK GSK Stock Holding History

GTS Securities’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-91,300
Closed -$3.73M – 2432
2024
Q3 		$3.73M Buy
91,300
+10,700
+13% +$438K 0.01% 1105
2024
Q2 		$3.1M Buy
80,600
+3,100
+4% +$130K 0.01% 1179
2024
Q1 		$3.32M Sell
77,500
-9,600
-11% -$396K 0.01% 1132
2023
Q4 		$3.23M Buy
87,100
+400
+0.5% +$14.4K 0.01% 1307
2023
Q3 		$3.14M Buy
+86,700
New +$3.08M 0.01% 1207

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

GTS Securities's GSK Position: Q3 2025 in Review

GTS Securities sold out of GSK (GSK) in Q3 2025, closing a stake of 10,054 shares — an estimated $386K sold.

GTS Securities first reported a position in GSK in Q2 2023 and held it in 5 quarters. The position peaked at $7.23M in Q3 2023. 895 funds tracked by Wall St. Rank hold GSK as of Q3 2025.

  • GTS Securities reported no remaining GSK position as of Q3 2025 after selling out during the quarter.
  • GTS Securities sold 10,054 GSK shares in Q3 2025, an estimated $386K.
  • GTS Securities first reported a position in GSK in Q2 2023 and held it in 5 quarters.
  • GTS Securities's GSK position peaked at $7.23M in Q3 2023.
  • 895 funds tracked by Wall St. Rank held GSK as of Q3 2025.

Based on GTS Securities's 13F filing for Q3 2025, filed 14 Nov 2025.